Baxter International, Inc. (BAX)
16.75
+0.13
(+0.78%)
USD |
NYSE |
May 05, 16:00
16.72
-0.03
(-0.18%)
After-Hours: 20:00
Baxter International Cash from Investing (Quarterly) : -133.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -183.00M |
| ResMed, Inc. | -58.03M |
| Abbott Laboratories | -20.32B |
| Boston Scientific Corp. | -591.00M |
| West Pharmaceutical Services, Inc. | -42.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 213.00M |
| Cash from Financing (Quarterly) | -11.00M |
| Free Cash Flow | 714.00M |
| Free Cash Flow Per Share (Quarterly) | 0.1476 |
| Free Cash Flow to Equity (Quarterly) | 169.00M |
| Free Cash Flow to Firm (Quarterly) | 291.33M |
| Free Cash Flow Yield | 8.29% |